222 related articles for article (PubMed ID: 11145483)
1. Venlafaxine for hot flushes.
Barlow DH
Lancet; 2000 Dec; 356(9247):2025-6. PubMed ID: 11145483
[No Abstract] [Full Text] [Related]
2. Nonhormonal agents show promise against hot flashes.
Gottlieb N
J Natl Cancer Inst; 2000 Jul; 92(14):1118-20. PubMed ID: 10904081
[No Abstract] [Full Text] [Related]
3. Treatment for hot flushes in women receiving tamoxifen.
Bydder SA; Spry NA
Med J Aust; 2002 Sep; 177(5):266. PubMed ID: 12197825
[No Abstract] [Full Text] [Related]
4. Venlafaxine hydrochloride for the treatment of hot flashes.
Schober CE; Ansani NT
Ann Pharmacother; 2003 Nov; 37(11):1703-7. PubMed ID: 14565812
[TBL] [Abstract][Full Text] [Related]
5. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.
Loprinzi CL; Pisansky TM; Fonseca R; Sloan JA; Zahasky KM; Quella SK; Novotny PJ; Rummans TA; Dumesic DA; Perez EA
J Clin Oncol; 1998 Jul; 16(7):2377-81. PubMed ID: 9667254
[TBL] [Abstract][Full Text] [Related]
6. Medroxyprogesterone acetate better than venlafaxine at relieving hot flashes.
J Support Oncol; 2005; 3(4):312. PubMed ID: 16092603
[No Abstract] [Full Text] [Related]
7. Breast cancer and hot flashes. Options for relief.
Mayo Clin Health Lett; 2001 Mar; 19(3):6. PubMed ID: 11242843
[No Abstract] [Full Text] [Related]
8. Venlafaxine hydrochloride and chronic pain.
Taylor K; Rowbotham MC
West J Med; 1996 Sep; 165(3):147-8. PubMed ID: 8909172
[No Abstract] [Full Text] [Related]
9. Beyond estrogen: new alternatives for the management of hot flashes.
Dvorak SR
S D J Med; 2002 Jan; 55(1):11-2. PubMed ID: 11808405
[No Abstract] [Full Text] [Related]
10. Venlafaxine: not yet first in the antidepressant class.
Harv Ment Health Lett; 2003 Apr; 19(10):5-7. PubMed ID: 12711568
[No Abstract] [Full Text] [Related]
11. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.
Evans ML; Pritts E; Vittinghoff E; McClish K; Morgan KS; Jaffe RB
Obstet Gynecol; 2005 Jan; 105(1):161-6. PubMed ID: 15625158
[TBL] [Abstract][Full Text] [Related]
12. Regarding "Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs".
Koesters M; Becker T; Weinmann S
Biol Psychiatry; 2009 Sep; 66(5):e7; authour reply e9-10. PubMed ID: 19520365
[No Abstract] [Full Text] [Related]
13. [A case report. Venlafaxine--new treatment of painful peripheral diabetic neuropathy].
Lithner F
Lakartidningen; 2000 Sep; 97(39):4311. PubMed ID: 11076473
[No Abstract] [Full Text] [Related]
14. Venlafaxine and SSRI remission data revisited.
Kavirajan H
Br J Psychiatry; 2004 May; 184():452-3. PubMed ID: 15123513
[No Abstract] [Full Text] [Related]
15. The review by Weinmann and colleagues.
Freemantle N
Psychopharmacology (Berl); 2008 Jul; 199(1):131-2; author reply 133-4. PubMed ID: 18504557
[No Abstract] [Full Text] [Related]
16. [Evidence-based pharmacoanalytics of using venlafaxine in clinical medicine].
Rachin AP; Sergeev AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):68-70. PubMed ID: 19938277
[No Abstract] [Full Text] [Related]
17. Venlafaxine versus sertraline for major depressive disorder.
Wise TN; Sheridan MJ
J Clin Psychiatry; 2000 Nov; 61(11):873-4. PubMed ID: 11105744
[No Abstract] [Full Text] [Related]
18. Venlafaxine augmentation with methylphenidate for treatment-refractory depression: a case report.
Bader GM; Hawley JM; Short DD
J Clin Psychopharmacol; 1998 Jun; 18(3):255-6. PubMed ID: 9617988
[No Abstract] [Full Text] [Related]
19. Flushing in a menopausal woman taking venlafaxine.
Grady-Weliky TA; Hartmann DM
Am J Psychiatry; 2001 Aug; 158(8):1330. PubMed ID: 11481177
[No Abstract] [Full Text] [Related]
20. Synergistic benefits of serotonin and noradrenaline reuptake inhibition.
Nelson JC
Depress Anxiety; 1998; 7 Suppl 1():5-6. PubMed ID: 9597344
[No Abstract] [Full Text] [Related]
[Next] [New Search]
